EUCTR2008-006413-25-GB进行中（未招募）不适用
A single-centre randomised, partially blind, single dose, crossover study investigating the onset of action of soothing and cooling after taking Gaviscon Peppermint liquid, Double Action Gaviscon liquid, Gaviscon Instants Oral Powder, compared to a control in subjects with heartburn following a refluxogenic meal, using the 2-stopwatch technique - Gaviscon Soothing and Cooling
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Only subjects to whom all of the following conditions apply will be included:
- •1) Age: = 18 years = 65 years.
- •2) Sex: Male and female subjects are eligible for entry.
- •3) Status: Members of the Simbec Volunteer Panel who state (self-rated) that they have a tendency to experience symptoms of heartburn related to reflux, following some meals.
- •4) Primary diagnosis: Those with self-rated at least moderate heartburn within 60 minutes following ingestion of a standardised refluxogenic meal at the second screening visit.
- •5) Subjects who have given written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subjects to whom any of the following conditions apply must be excluded:
- •1) Those who have suffered a recent, significant unexplained weight loss of 6-7kg in the last 6 months.
- •2) Those who have experienced any gastrointestinal bleeding within the last 12 months.
- •3) Those with difficulty in swallowing.
- •4) Those with a history and/or symptom profile suggestive of Zollinger-Ellison syndrome, gastric carcinoma, previous or current peptic ulcer disease, pernicious anaemia, Barrett’s oesophagus or systemic sclerosis.
- •5) Those with known hypophosphataemia or phenylketonuria.
- •6) Those with severe constipation or history of colonic stenosis.
- •7) Those who have taken any antacids, H2 antagonists, motility stimulants/prokinetics or other medicines for relief of symptoms of acid reflux disease within the previous 24 hours prior to Screening Visit 2.
- •8) Those who have taken proton pump inhibitors within the previous 48 hours prior to Screening Visit 2.
- •9) Those with a history of drug, solvent or alcohol abuse.
- •10) Those with any previous history of allergy or known intolerance to any of the study drugs or following formulation constituents, sodium alginate, calcium carbonate, sodium carbonate, potassium bicarbonate, or hydroxybenzoate (parabens).
- •11) Those who have a history of cardiovascular disorders or show evidence of clinically significant cardiovascular disease.
- •12) Those with any previous history of allergy or known intolerance to milk, soya, or wheat.
- •13) Those who are receiving treatment for their upper gastrointestinal problems or gastro-oesophageal reflux disease from their GP.
- •14) Those unable in the opinion of the Investigator to comply fully with the study requirements.
- •15) Those currently participating in a clinical study or who have participated in any other clinical study within the last 30 days.
- •16) Those who have previously participated in this randomised study.
- •17) Woman of childbearing potential, who are pregnant or lactating, seeking pregnancy or failing to take adequate contraceptive precautions, (i.e. an oral or injectable contraceptive, an approved hormonal implant or topical patch, an intrauterine device, abstinence [should the subject become sexually active, she must agree to use a double barrier method] or condoms/diaphragm and spermicide). A woman of childbearing potential is defined as any female who is less than 2 years post-menopausal or has not undergone an hysterectomy or surgical sterilisation, e.g. bilateral tubal ligation, bilateral ovariectomy (oophorectomy).
- •18) Those who are on steroids or non-steroidal anti-inflammatory drugs.
- •19) Those who are diabetics.
研究者
相似试验
进行中（未招募）
不适用
A single-centre randomised, partially blind, single dose, crossover pilot study investigating the use of stopwatches to assess the onset of action of soothing and cooling of Gaviscon Peppermint Liquid, Double Action Gaviscon Liquid, Gaviscon Advance Liquid and a control in subjects with heartburn following a refluxogenic meal.Symptoms of heartburnEUCTR2007-005821-31-GBReckitt Benckiser Healthcare UK) Limited
进行中（未招募）
不适用
A single centre, randomised, partially-blind, placebo-controlled 3 way crossover pilot study investigating efficacy in terms of heartburn relief after taking (2x250mg) Gaviscon® chewable tablets, (1x20mg) Losec® MUPS® tablet and (2x) Placebo tablets in subjects with heartburn following a refluxogenic meal. - Three-period crossover pilot study in healthy subjects susceptible to heartburn.Investigating efficacy in terms of heatburn relief in healthy subjects following a refluxogenic meal.EUCTR2010-019414-24-GBReckitt Benckiser Healthcare (UK) Ltd
已完成
Unknown
To study the colur, thickness, taste, smell of a syrup in children.CTRI/2023/04/052120Cipla Ltd.55
进行中（未招募）
不适用
A single center, randomized, partially blind, placebocontrolled, crossover, single oral dose study to assess theeffect of concomitant antacid (calcium carbonate) on thepharmacokinetics and pharmacodynamics of SMC021 (0.8mg salmon calcitonin/200 mg 5-CNAC) in healthypostmenopausal womeOsteoporosis, osteoarthritisMedDRA version: 8.1Level: LLTClassification code 10031282Term: OsteoporosisEUCTR2006-004177-95-DKovartis Pharma Services AG38
进行中（未招募）
1 期
A single centre, randomised, single blind, parallel group single dose study to compare the speed of onset of ibuprofen gel, ibuprofen gel with levomenthol and diclofenac gel in the relief of pain from strains, sprains and sports injuriesPain of strains, sprains and sports injuriesMedDRA version: 18.1 Level: PT Classification code 10065016 Term: Post-traumatic pain System Organ Class: 10022117 - Injury, poisoning and procedural complicationsEUCTR2015-005240-33-GBThe Mentholatum Company Ltd182